References
- Lalouschek W, Aull S, Series W, Zeiler K. The prothrombin G20210 A mutation and factor V Leiden mutation in patients with cerebrovascular disease. Blood. 1998;92:704–705.
- De Stefano V, Chiusolo P, Paciaroni K, et al. Prothrombin G20210 A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;91:3562–3565.
- Longstercth WT Jr, Rosendaal FR, Siscovick DS, et al. Risk of stroke in young women and two prothrom-botic mutations: factor V Leiden and prothrombin gene variant (G20210 A). Stroke. 1998;29:577–580.
- Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg 506—. Gln mutation. Blood Coagul Fibrinolysis. 1995;6:245–248.
- Poort SR, Rosendaal FR, Reitsma PH, Berlina RM. A common genetic variation in the 3' untranslated region of the protrombin gene is associated with elevated plasma protrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703.
- Akar N, Akar E, Dalgm G, Si5zili5z A, Omürlü K, Gin S. Frequency of factor V (1691G-A) mutation in the Turkish population. Thromb Haemost. 1997;78: 1527–1529.
- Akar N, Misirhoglu M, Akar E, Avcu F, Yakin A, Si5zili5z A. Prothrombin gene 20210 G-A mutation in the Turkish population. AmJ Hematol. 1998;58: 249.
- Giirgey A, Hiçsônmez G, Parlak H, Balta G, celiker A. Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol. 1998;59: 179.